---
title: "Storage Firms Surge 980% as Shipping Lines Ride Red Sea Premium"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300546322.md"
description: "Guoxia Technology's H1 profit surged 980% on Siemens partnership. T.S. Lines generated US$13 million from Red Sea rerouting with 23.3% net income growth. CIDI's order backlog reached RMB 200 million while Transcenta's revenue jumped 770% on licensing deals. Sector aligns with carbon neutrality push."
datetime: "2026-09-30T09:18:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300546322.md)
  - [en](https://longbridge.com/en/news/300546322.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300546322.md)
generator: "portal-rs"
---

# Storage Firms Surge 980% as Shipping Lines Ride Red Sea Premium

Guoxia Technology (2799.HK) reported a staggering 980% year-on-year profit surge in the first half of 2026, driven by its strategic partnership with Siemens China for AI-integrated energy storage solutions. The collaboration targets smart grid optimization and zero-carbon industrial parks, with pilot projects already operational in three provinces.

T.S. Lines (3881.HK) emerged as a red-hot shipping play, generating US$13 million in incremental revenue from Red Sea rerouting during H1. Its net income rose 23.3% to US$232.6 million as JPMorgan lifted the target price to HK$18, citing robust freight rates and shareholder-friendly policies.

CIDI Inc. (6628.HK) solidified its mining autonomy leadership with RMB 200 million in order backlog. The company deployed 70-ton electric autonomous haul trucks at Yangtze River Basin mines and launched Xiao Yuan, the industry’s first mining-focused AI agent operating across 15 sites.

Transcenta Holding (3880.HK) saw revenue jump 770.42% to HK$23.6 million on WuXi Biologics licensing deals, while Medtide Inc. (2510.HK) expanded CDMO capacity through a 30-mu land acquisition in Hangzhou. China CITIC Financial Asset Management (2655.HK) posted 18.6% net profit growth with distressed asset disposal revenue doubling year-on-year.

HJ Science (6132.HK) approved corporate renaming and share repurchase authorization at its special general meeting, aiming to streamline governance structure for its precision manufacturing pivot.

### Related Stocks

- [02510.HK](https://longbridge.com/en/quote/02510.HK.md)
- [02655.HK](https://longbridge.com/en/quote/02655.HK.md)
- [02799.HK](https://longbridge.com/en/quote/02799.HK.md)
- [03880.HK](https://longbridge.com/en/quote/03880.HK.md)
- [03881.HK](https://longbridge.com/en/quote/03881.HK.md)
- [06132.HK](https://longbridge.com/en/quote/06132.HK.md)
- [06628.HK](https://longbridge.com/en/quote/06628.HK.md)

## Related News & Research

- [HJ Science Files Next Day Disclosure Return With HKEX Announcing Share Buyback](https://longbridge.com/en/news/306257418.md)
- [Medtide adopts 2026 RSU scheme with 10% share mandate limit](https://longbridge.com/en/news/305945125.md)
- [HJ Science Files Next-Day Disclosure With HKEX Announcing Share Buyback](https://longbridge.com/en/news/305810469.md)
- [HJ Science Files Next Day Disclosure Return With HKEX on Share Buyback](https://longbridge.com/en/news/305946100.md)
- [HJ Science Files Next Day Disclosure Return to HKEX Announcing Share Buyback](https://longbridge.com/en/news/305444005.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**